Sarah Warda

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 3

Top Topics

Chronic Myeloid Leukemia

Tyrosine Kinase

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Miguel A Miranda-Román, Cindy J Lee, Eve Fishinevich, Leili Ran, Amish J Patel, Juan Yan, Makhzuna N Khudoynazarova, Sarah Warda, Mohini R Pachai, Juliet Chen, Ping Chi
MEK inhibitors lead to PDGFR pathway upregulation and sensitize tumors to RAF dimer inhibitors in NF1-deficient malignant peripheral nerve sheath tumor (MPNST). Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Ping Chi, Li-Xuan Qin, Bastien Nguyen, Ciara M Kelly, Sandra P D' Angelo, Mark A Dickson, Mrinal M Gounder, Mary L Keohan, Sujana Movva, Benjamin A Nacev, Evan Rosenbaum, Katherine A Thornton, Aimee M Crago, Sam Yoon, Gary A Ulaner, Randy Yeh, Moriah Martindale, Haley T Phelan, Matthew D Biniakewitz, Sarah Warda, Cindy J Lee, Michael F Berger, Samuel Singer, Sinchun Hwang, Yu Chen, Cristina R Antonescu, William D Tap
Phase II Trial of Imatinib Plus Binimetinib in Patients With Treatment-Naive Advanced Gastrointestinal Stromal Tumor. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (9) (2022)
Amish J Patel, Sarah Warda, Jesper L V Maag, Rohan Misra, Miguel A Miranda-Román, Mohini R Pachai, Cindy J Lee, Dan Li, Naitao Wang, Gabriella Bayshtok, Eve Fishinevich, Yinuo Meng, Elissa W P Wong, Juan Yan, Emily Giff, Melissa B Pappalardi, Michael T McCabe, Jonathan A Fletcher, Charles M Rudin, Sarat Chandarlapaty, Joseph Michael Scandura, Richard P Koche, Jacob Lowell Glass, Cristina R Antonescu, Deyou Zheng, Juliet Chen, Ping Chi
PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry. Cancer discovery 12 (9) (2022)